How stress reduces sperm motility by altering mitochondria

Researchers investigate the effects of perceived stress on sperm motility and maturation.

Pharmalittle: We’re reading about AstraZeneca CEO pay, alternatives to WuXi and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

April 12, 2024

Structure’s oral GLP-1 a ‘work in progress’ following Phase IIa obesity and diabetes data

Phase IIa data for Structure Therapeutics’ oral GLP-1 drug candidate for type 2 diabetes and obesity bested analyst expectations on safety and tolerability, but lower-than-hoped-for

December 19, 2023

Teprotumumab Improves Thyroid Eye Disease Across Phenotypes

NEW ORLEANS — Comparable improvements were observed with teprotumumab (Tepezza) between patients with age-related phenotypic I or II thyroid eye disease, according to results from

May 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.